课题基金 / 基金详情

Development of molecular and cellular-targeting DNA vaccine against Mycobacterium tuberculosis and analysis of its mechanism

Development of molecular and cellular-targeting DNA vaccine against Mycobacterium tuberculosis and analysis of its mechanism
结核分枝杆菌分子细胞靶向DNA疫苗的研制及其机制分析
批准号:
18590417
负责人:
UCHIJIMA Masato
金额:
$2.36万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

UCHIJIMA Masato的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chemokines bind to specific cell-surface receptors which are internalized after binding of ligands. Chemokine receptors are differentially expressed on a variety of immune cells. Sentinel antigen-presenting cells (APCs), such as immature dendritic cells (DCs) and macrophages, express chemokine receptors such CCR5. We applied the receptor binding and internalization of chemokine to vaccination against Mycobacterium tuberculosis. First, we examined binding and internalization of MIP-1α (CCR5 ligand) -GFP fusion protein by confocal microscopy analysis using DCs and macrophage cells- GFP fusion protein was found to bind to surface of these cells and to be internalized into cells and colocalized with CCR5. To construct a DNA vaccine, we used MPT51, a major secreted protein of M tuberculosis, since we demonstrated that the MPT51 could induce T-cell-mediated immune responses and protective immunity upon challenge with M tuberculosis. MIP-la and MPT51 genes were ligated via short 14-amino acid … More spacer sequence and cloned into mammalian expression vector pCI. BALB/c mice were immunized three times biweekly with pCI-MPT51 or pCI- MIP-1α -MPT51 (fusion) or pCI-MPT51 +pCI-MIP1α (mixture) using Helios gene gun system. After three days form last immunization, MHC-tetramer assay was performed to measure MPT51-specific CD8^+ T cells. Numbers of the antigen specific CD8^+ T cells were higher in mice immunized with the fusion DNA vaccine than those of mice immunized with DNA vaccine encoding MPT51 alone. Amounts of antigen-specific IFN-γ mRNA increased in spleen cells from fusion DNA vaccine-immunized mice in compared with those of pCI-MPT51- or pCI-MPT51 +pCI-MIP1α -immunized mice. Mice immunized with the fusion DNA vaccine produced highest level of MPT51-specific IFN-γ protein among these three DNA vaccination patterns. Furthermore, spleen cells from C57/BL6 mice immunized with these DNA vaccines were stimulated by CDC T-cell epitope peptide of MPT51. C57/BL6 mice immunized with fusion DNA vaccine produced higher level of antigen-specific IFN-γ mRNA and protein than those of mice immunized with pCI-MPT51.These results suggest that MIP-la-antigen fusion proteins encoded by DNA vaccine vector are efficiently internalized into antigen presenting cells and induce higher level of antigen specific T cell responses Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intratracheal administration of third-generation of lentivirus vector encoding MPT51 from Mycobacterium tuberculosis induces specific CD8+ T cell respaises in lung
气管内注射编码结核分枝杆菌 MPT51 的第三代慢病毒载体可诱导肺部特异性 CD8 T 细胞恢复
DOI: --
发表时间: 2008
期刊: Vaccine
影响因子: 5.5
作者: [Hashimoto, D., et. al.]
通讯作者: et. al.
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [瀬戸真太郎, 他]
通讯作者:
Genetic fusion of MIP-1α to a mycobacterial MPT51 antigen enhances the antigen-specific CD8^+ T-and CD4^+ T-cell responses
MIP-1α 与分枝杆菌 MPT51 抗原的基因融合增强了抗原特异性 CD8^+ T 细胞和 CD4^+ T 细胞反应
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [内嶋雅人, 他]
通讯作者:
Immunization with dendritic cells pulsesd with α-galactocylceramide and a dominant CTL epitope elicits effective protective immunity against intracellular bacteria infection.
用 α-半乳酰神经酰胺和优势细菌 CTL 表位脉冲的树突状细胞进行免疫,可引发针对细胞内感染的有效保护性免疫。
DOI: --
发表时间: 2006
期刊: Int. J. Infect. Dis. 10
影响因子: --
作者: [Enomoto, N., Nagata, T., Suda, T., Uchijima, M., Chida, K., Nakamura, H., Koide, Y.]
通讯作者: Y.
32
    Analysis of genes induced by bacterial immunostimulatory CpG-DNA
    • 批准号:
      13670269
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      2001
    • 负责人:
      UCHIJIMA Masato
    • 依托单位:
    海外基金